<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EEAD610A-86B4-4234-97E2-6D2494FCD6EE"><gtr:id>EEAD610A-86B4-4234-97E2-6D2494FCD6EE</gtr:id><gtr:firstName>Ruth</gtr:firstName><gtr:surname>Pepper</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802260"><gtr:id>726AB0AA-8DC1-4634-967D-028170AC76D1</gtr:id><gtr:title>Renal mesangial cell-macrophage interactions and the outcome of glomerulonephritis.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0802260</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>ANCA-associated vasculitides (AAV) and systemic lupus erythematosus (SLE) are autoimmune disorders that may result in glomerulonephritis, resulting in end stage kidney disease and a poor clinical outcome. The factors that determine particular organ involvement remain obscure, and the susceptibility to renal disease in certain individuals is therefore unknown. In both conditions, development of glomerulonephritis is critically associated with renal macrophage infiltration. However, recent evidence has highlighted the different macrophage phenotypes that may be generated and the altered outcomes of inflammation associated with them. Moreover, it has been reported that interaction of intrinsic renal cells with infiltrating leukocytes can influence the outcome of glomerulonephritis, but the mechanisms mediating these effects are not completely understood. I hypothesize that renal mesangial cell expression of mannose receptor and activatory Fc receptors promotes a pro-inflammatory macrophage phenotype and predisposes to glomerulonephritis. By contrast, mannose receptor deficiency or altered activatory:inhibitory Fc receptor expression ratio promotes an anti-inflammatory phenotype and will be associated with glomerular protection from disease. Our laboratory has already confirmed some of these findings in murine models of disease, but this has not been tested in clinical AAV/SLE or using human cells. I will test this idea by studying receptor expression in mesangial cells and macrophages in human disease and their interaction in vitro using a co-culture system. 

I will use a variety of experimental techniques, including flow cytometry, real time PCR immunohistochemistry and ELISA to investigate receptor expression and cell phenotype, using renal biopsy material from patients, and laser capture microdissection of their glomeruli. Levels of expression will be correlated with clinical outcome and will be compared to that in disease controls. Additionally, cell culture experiments will allow specific manipulation of one or other receptor type, using RNA interference techniques, and the investigation, following such manipulation, of macrophage phenotype. These data will allow us to translate murine studies to the clinical setting and investigate whether these receptors may be novel targets for treatment of human disease.</gtr:technicalSummary><gtr:fund><gtr:end>2012-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>394064</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>27649E02-FBFE-4917-8F83-25A1F2DEE060</gtr:id><gtr:title>S100A8/A9 (calprotectin) is critical for development of glomerulonephritis and promotes inflammatory leukocyte-renal cell interactions.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fde02352204dc97dbc4b2d2bcabbcae"><gtr:id>2fde02352204dc97dbc4b2d2bcabbcae</gtr:id><gtr:otherNames>Pepper RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>56e060a4010e33.84935479</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C9245B5-67A6-4028-822D-5DABA08D3EB5</gtr:id><gtr:title>Elevated soluble Flt1 inhibits endothelial repair in PR3-ANCA-associated vasculitis.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd013df2fc7a4f639925461bea58bc23"><gtr:id>bd013df2fc7a4f639925461bea58bc23</gtr:id><gtr:otherNames>Le Roux S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>rKMfYaRvNMb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14297689-9925-4D07-96CA-56352085CB2C</gtr:id><gtr:title>Local IL-17 Production Exerts a Protective Role in Murine Experimental Glomerulonephritis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2916054640c34c499aea7aaff70d85f0"><gtr:id>2916054640c34c499aea7aaff70d85f0</gtr:id><gtr:otherNames>Hamour S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675eae152205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8129A55F-FF19-4024-862F-F79923C79191</gtr:id><gtr:title>Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis.</gtr:title><gtr:parentPublicationTitle>Kidney international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2fde02352204dc97dbc4b2d2bcabbcae"><gtr:id>2fde02352204dc97dbc4b2d2bcabbcae</gtr:id><gtr:otherNames>Pepper RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0085-2538</gtr:issn><gtr:outcomeId>dvg5pzGNQKk</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802260</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>2EEE0958-6BE1-4D16-B86B-5D954CD37219</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Renal and Urogenital</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>